Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Citations in academic papers are intended to ground research in the ...

This story was reported by Lizzy Lawrence, Matthew Herper, Isabella Cueto, Elizabeth Cooney, Andrew Joseph, Daniel Payne, and Helen Branswell. For more than a half-century, the Centers for Disease ...

Far fewer knew that mpox and Zika can also be transmitted sexually. And most respondents understood the main ways that these ...

Supporters worry that a men’s health office created by the Trump administration risks being dismantled by a future Democratic ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — There was broad ...

Jeffery Taubenberger, the acting head of the NIAID, the NIH’s infectious disease institute, is reported to have stepped down.

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the ...

The company behind the analytics, Vizient, touts MGH's increasing hospice enrollment to improved mortality performance.

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

My patients are replacing olive oil with beef tallow, even if they don't tell me during cardiac rehab,” writes a clinical ...